Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNTG

Centogene (CNTG) Stock Price, News & Analysis

Centogene logo

About Centogene Stock (NASDAQ:CNTG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.07
$0.35
52-Week Range
N/A
Volume
8.36 million shs
Average Volume
150,868 shs
Market Capitalization
$8.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Centogene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

CNTG MarketRank™: 

Centogene scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Centogene.

    • Short Interest

      There is no current short interest data available for CNTG.
    • Dividend Yield

      Centogene does not currently pay a dividend.

    • Dividend Growth

      Centogene does not have a long track record of dividend growth.

    • Short Interest

      There is no current short interest data available for CNTG.
    • Search Interest

      1 people have searched for CNTG on MarketBeat in the last 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Centogene insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 1.93% of the stock of Centogene is held by insiders.

    • Percentage Held by Institutions

      Only 9.94% of the stock of Centogene is held by institutions.

    • Read more about Centogene's insider trading history.
    Receive CNTG Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    CNTG Stock News Headlines

    Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
    While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.tc pixel
    CNTGF Centogene N.V.
    Centogene N.V. (CNTG)
    See More Headlines

    CNTG Stock Analysis - Frequently Asked Questions

    Centogene (NASDAQ:CNTG) announced its earnings results on Wednesday, November, 24th. The company reported ($1.08) EPS for the quarter, missing the consensus estimate of ($0.59) by $0.49. The firm had revenue of $35.60 million for the quarter, compared to the consensus estimate of $31.91 million.

    Centogene (CNTG) raised $60 million in an IPO on Thursday, November 7th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. SVB Leerink and Evercore ISI served as the underwriters for the IPO and Baird and BTIG were co-managers.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Centogene investors own include Avino Silver & Gold Mines (ASM), Lincoln National (LNC), Advanced Micro Devices (AMD), Applied Genetic Technologies (AGTC), Catalyst Pharmaceuticals (CPRX), Fulcrum Therapeutics (FULC) and VBI Vaccines (VBIV).

    Company Calendar

    Last Earnings
    11/24/2021
    Today
    9/01/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Medical laboratories
    Sub-Industry
    Healthcare
    Current Symbol
    NASDAQ:CNTG
    CIK
    1757097
    Fax
    N/A
    Employees
    810
    Year Founded
    N/A

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    1.02
    Quick Ratio
    0.96

    Sales & Book Value

    Annual Sales
    $48.54 million
    Price / Sales
    0.00
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($1.01) per share
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    27,080,000
    Free Float
    N/A
    Market Cap
    $8.80 million
    Optionable
    Not Optionable
    Beta
    -0.67

    Social Links

    Options Trading Made Easy - Download Now Cover

    Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

    Get This Free Report

    This page (NASDAQ:CNTG) was last updated on 9/1/2025 by MarketBeat.com Staff
    From Our Partners